25 results
8-K/A
EX-99.1
QNCX
Quince Therapeutics Inc
5 Jan 24
Independent Auditors’ Report
4:01pm
provided by Invitalia as part of the “Brevetti +” program, as per the Mise program for the development of patents and innovative projects by SMEs
8-K
EX-2.1
iomcy719j5
24 Jul 23
Entry into a Material Definitive Agreement
7:16am
8-K
EX-99.2
oqrr92ewu3v
24 Jul 23
Entry into a Material Definitive Agreement
7:16am
8-K
EX-99.1
c7diyjecx 9jul
5 Apr 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-99.1
nhfrptyi0o2ragw
1 Aug 22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
9:17am
8-K
EX-99.1
ojxx2cj
10 May 22
Cortexyme Announces Agreement to Acquire Novosteo
8:08am
10-K
swyf5 2toe
16 Mar 20
Annual report
4:16pm